Vidaza and Neoplasm progression - a phase IV clinical study of FDA data

Summary:

Neoplasm progression is reported as a side effect among people who take Vidaza (azacitidine), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Bleomycin Sulfate, and have Hodgkin's lymphoma.

The phase IV clinical study analyzes which people have Neoplasm progression when taking Vidaza. It is created by eHealthMe based on reports of 12,799 people who have side effects when taking Vidaza from the FDA, and is updated regularly.

What is Vidaza?

Vidaza has active ingredients of azacitidine. It is often used in myelodysplastic syndrome. eHealthMe is studying from 12,837 Vidaza users. Check the latest studies of Vidaza.

What is Neoplasm progression?

Neoplasm progression (growth of tumour) is found to be associated with 1,065 drugs and 915 conditions by eHealthMe. Check the latest studies of Neoplasm progression.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

12,799 people reported to have side effects when taking Vidaza.
Among them, 77 people (0.6%) have Neoplasm progression.

Could Vidaza cause Neoplasm progression?

Among these 77 people:

How long have people been on Vidaza when they have Neoplasm progression? *

What is the gender of people who have Neoplasm progression when taking Vidaza? *

female: 33.85 %
male: 66.15 %

What is the age of people who have Neoplasm progression when taking Vidaza? *

What are other drugs people take besides Vidaza? *

What are other side effects people have besides Neoplasm progression? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 30 people, 38.96%
Second Primary Malignancy (after getting cure a cancer, a new cancer development): 14 people, 18.18%
Myositis (inflammation of the muscles): 14 people, 18.18%
Anaemia (lack of blood): 12 people, 15.58%
Thrombocytopenia (decrease of platelets in blood): 12 people, 15.58%
Fever: 10 people, 12.99%
Death: 10 people, 12.99%
Pneumonia: 10 people, 12.99%
Infection: 9 people, 11.69%
Nausea (feeling of having an urge to vomit): 9 people, 11.69%

What are the existing conditions these people have? *

Hodgkin's Lymphoma (cancer originating from white blood cells): 14 people, 18.18%
Iron Overload: 6 people, 7.79%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 7.79%
Hodgkin's Disease Recurrent (cancer originating from white blood cells -recurrent): 5 people, 6.49%
Haemochromatosis (body to absorb more iron than usual from food): 4 people, 5.19%
Magnesium Metabolism Disorder (disease of magnesium utilization): 3 people, 3.90%
Lymphoproliferative Disorder (a medical condition in which the immune system makes too many white blood cells): 3 people, 3.90%
Oedema (fluid collection in tissue): 2 people, 2.60%
Disease Progression: 2 people, 2.60%
Pain: 1 person, 1.30%

* Approximation only. Some reports may have incomplete information.

Do you take Vidaza and have Neoplasm progression?

- Check whether Neoplasm progression is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vidaza:

Vidaza (12,837 reports)

Browse all side effects of Vidaza:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm progression:

Neoplasm progression (1,065 drugs)

Browse all the conditions that are associated with Neoplasm progression:

Neoplasm progression (915 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on azacitidine (the active ingredients of Vidaza) and Vidaza (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.